Cationic Leciplex Nanocarriers for Oral Delivery of Vancomycin Hydrochloride: Design Optimization and Pharmacokinetic Evaluation
Pharmaceutical Sciences and Drug Design · 2026 · 6 (2) · 130-148
DOI: 10.51847/p78cofv6m5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Sciences and Drug Design, 2026. Verfasst von Jinwoo Park und 2 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben.
Abstract (Originalsprache)
The aim was to examine how the cationic nanocarrier leciplex (LPX) could boost the oral bioavailability of vancomycin hydrochloride (VAN) through enhancement of its permeation across the intestinal wall. A D-optimal design was employed to evaluate the impact of several variables—namely, lipid molar ratio, cationic surfactant molar ratio, cationic surfactant type, and lipid type—on the attributes of LPX, such as entrapment efficiency (EE%), particle size (P.S.), polydispersity index (P.I.), zeta
Zitieren
APA
Park, J., Kim, M., & Lee, S. (2026). Cationic Leciplex Nanocarriers for Oral Delivery of Vancomycin Hydrochloride: Design Optimization and Pharmacokinetic Evaluation. Pharmaceutical Sciences and Drug Design, 6(2), 130-148. https://doi.org/10.51847/p78cofv6m5
Vancouver
Park J, Kim M, Lee S. Cationic Leciplex Nanocarriers for Oral Delivery of Vancomycin Hydrochloride: Design Optimization and Pharmacokinetic Evaluation. Pharmaceutical Sciences and Drug Design. 2026;6(2):130-148. doi:10.51847/p78cofv6m5
BibTeX
@article{Park2026,
author = {Park, Jinwoo and Kim, Minji and Lee, Seung},
title = {Cationic Leciplex Nanocarriers for Oral Delivery of Vancomycin Hydrochloride: Design Optimization and Pharmacokinetic Evaluation},
journal = {Pharmaceutical Sciences and Drug Design},
year = {2026},
volume = {6},
number = {2},
pages = {130--148},
doi = {10.51847/p78cofv6m5}
}
EUVIMED